Logo image of NBIS

NEBIUS GROUP NV (NBIS) Stock Fundamental Analysis

NASDAQ:NBIS - Nasdaq - NL0009805522 - Common Stock - Currency: USD

39.835  -6.41 (-13.87%)

After market: 40.0398 +0.2 (+0.51%)

Fundamental Rating

4

NBIS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 71 industry peers in the Interactive Media & Services industry. While NBIS has a great health rating, there are worries on its profitability. NBIS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year NBIS has reported negative net income.
NBIS had positive earnings in 4 of the past 5 years.
NBIS had a positive operating cash flow in each of the past 5 years.
NBIS Yearly Net Income VS EBIT VS OCF VS FCFNBIS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20B -20B 40B

1.2 Ratios

NBIS has a worse Return On Assets (-237.81%) than 96.97% of its industry peers.
NBIS has a worse Return On Equity (-248.69%) than 81.82% of its industry peers.
The Return On Invested Capital of NBIS (51.77%) is better than 98.48% of its industry peers.
Industry RankSector Rank
ROA -237.81%
ROE -248.69%
ROIC 51.77%
ROA(3y)1.19%
ROA(5y)2.55%
ROE(3y)2.29%
ROE(5y)4.2%
ROIC(3y)N/A
ROIC(5y)N/A
NBIS Yearly ROA, ROE, ROICNBIS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20

1.3 Margins

NBIS's Profit Margin has declined in the last couple of years.
NBIS has a Operating Margin of 1.02%. This is comparable to the rest of the industry: NBIS outperforms 53.03% of its industry peers.
In the last couple of years the Operating Margin of NBIS has declined.
The Gross Margin of NBIS (53.85%) is worse than 60.61% of its industry peers.
NBIS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.02%
PM (TTM) N/A
GM 53.85%
OM growth 3Y-19.82%
OM growth 5Y-25.69%
PM growth 3Y-39.69%
PM growth 5Y-41.43%
GM growth 3Y-3.25%
GM growth 5Y-5.21%
NBIS Yearly Profit, Operating, Gross MarginsNBIS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so NBIS is creating value.
NBIS has about the same amout of shares outstanding than it did 1 year ago.
NBIS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NBIS has a worse debt to assets ratio.
NBIS Yearly Shares OutstandingNBIS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
NBIS Yearly Total Debt VS Total AssetsNBIS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200B 400B 600B

2.2 Solvency

An Altman-Z score of 138.03 indicates that NBIS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 138.03, NBIS belongs to the top of the industry, outperforming 98.48% of the companies in the same industry.
NBIS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 138.03
ROIC/WACC13.88
WACC3.73%
NBIS Yearly LT Debt VS Equity VS FCFNBIS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100B 200B 300B

2.3 Liquidity

A Current Ratio of 22.24 indicates that NBIS has no problem at all paying its short term obligations.
NBIS has a Current ratio of 22.24. This is amongst the best in the industry. NBIS outperforms 98.48% of its industry peers.
NBIS has a Quick Ratio of 22.24. This indicates that NBIS is financially healthy and has no problem in meeting its short term obligations.
NBIS has a better Quick ratio (22.24) than 98.48% of its industry peers.
Industry RankSector Rank
Current Ratio 22.24
Quick Ratio 22.24
NBIS Yearly Current Assets VS Current LiabilitesNBIS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100B 200B 300B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for NBIS have decreased strongly by -124.77% in the last year.
Measured over the past years, NBIS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -66.92% on average per year.
NBIS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -65.10%.
The Revenue for NBIS have been decreasing by -42.30% on average. This is quite bad
EPS 1Y (TTM)-124.77%
EPS 3Y-80.2%
EPS 5Y-66.92%
EPS Q2Q%-102.28%
Revenue 1Y (TTM)-65.1%
Revenue growth 3Y-66.56%
Revenue growth 5Y-42.3%
Sales Q2Q%-99.98%

3.2 Future

Based on estimates for the next years, NBIS will show a very negative growth in Earnings Per Share. The EPS will decrease by -1144.00% on average per year.
Based on estimates for the next years, NBIS will show a very strong growth in Revenue. The Revenue will grow by 195.91% on average per year.
EPS Next Y-21103.62%
EPS Next 2Y-1144%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year75.03%
Revenue Next 2Y195.91%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NBIS Yearly Revenue VS EstimatesNBIS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100B 200B 300B 400B 500B
NBIS Yearly EPS VS EstimatesNBIS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NBIS. In the last year negative earnings were reported.
Also next year NBIS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NBIS Price Earnings VS Forward Price EarningsNBIS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NBIS is valued cheaper than 96.97% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.83
NBIS Per share dataNBIS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800 1K

4.3 Compensation for Growth

A cheap valuation may be justified as NBIS's earnings are expected to decrease with -1144.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1144%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NBIS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEBIUS GROUP NV

NASDAQ:NBIS (2/21/2025, 8:00:01 PM)

After market: 40.0398 +0.2 (+0.51%)

39.835

-6.41 (-13.87%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)02-20 2025-02-20/bmo
Earnings (Next)04-24 2025-04-24
Inst Owners35.1%
Inst Owner ChangeN/A
Ins Owners4.45%
Ins Owner ChangeN/A
Market Cap9.38B
Analysts82.86
Price Target52.02 (30.59%)
Short Float %5.73%
Short Ratio1.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 3.26
P/tB 3.27
EV/EBITDA 2.83
EPS(TTM)-20.66
EYN/A
EPS(NY)-83.02
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1060.42
BVpS12.21
TBVpS12.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -237.81%
ROE -248.69%
ROCE 87.63%
ROIC 51.77%
ROICexc 245.99%
ROICexgc 249.55%
OM 1.02%
PM (TTM) N/A
GM 53.85%
FCFM N/A
ROA(3y)1.19%
ROA(5y)2.55%
ROE(3y)2.29%
ROE(5y)4.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-77.85%
ROICexcg growth 5Y-60.47%
ROICexc growth 3Y-77.04%
ROICexc growth 5Y-63.15%
OM growth 3Y-19.82%
OM growth 5Y-25.69%
PM growth 3Y-39.69%
PM growth 5Y-41.43%
GM growth 3Y-3.25%
GM growth 5Y-5.21%
F-ScoreN/A
Asset Turnover83.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 22.24
Quick Ratio 22.24
Altman-Z 138.03
F-ScoreN/A
WACC3.73%
ROIC/WACC13.88
Cap/Depr(3y)162.51%
Cap/Depr(5y)147%
Cap/Sales(3y)11.81%
Cap/Sales(5y)11.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-124.77%
EPS 3Y-80.2%
EPS 5Y-66.92%
EPS Q2Q%-102.28%
EPS Next Y-21103.62%
EPS Next 2Y-1144%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-65.1%
Revenue growth 3Y-66.56%
Revenue growth 5Y-42.3%
Sales Q2Q%-99.98%
Revenue Next Year75.03%
Revenue Next 2Y195.91%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-92.26%
EBIT growth 3Y-73.19%
EBIT growth 5Y-57.12%
EBIT Next Year-9054.64%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y96.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-98.28%
OCF growth 3Y-71.98%
OCF growth 5Y-52.02%